(Q28304978)

6

Anna Kajaste-Rudnitski

0 references

Giulia Escobar

Giulia Escobar

1

0 references

Roberta Mazzieri

Roberta Mazzieri

10

0 references

Mario Leonardo Squadrito

Mario Leonardo Squadrito

5

0 references

Bernhard Gentner

Bernhard Gentner

8

0 references

Michele De Palma

9

Michele De Palma

0 references

author name string

Davide Moi

2

0 references

Anna Ranghetti

3

0 references

Pinar Ozkal-Baydin

4

0 references

Attilio Bondanza

Science Translational Medicine

7

0 references

language of work or name

English

0 references

publication date

1 January 2014

0 references

published in

0 references

volume

6

0 references

issue

217

0 references

page(s)

217ra3

0 references

cites work

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3006353

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3006353

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3006353

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3006353

Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3006353

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3006353

ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3006353

Natural innate and adaptive immunity to cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

A critical function for type I interferons in cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Direct effects of type I interferons on cells of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Interferon: current status and future prospects in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Interferon-α in acute myeloid leukemia: an old drug revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Interferon-alpha therapy in bcr-abl-negative myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

IFNalpha activates dormant haematopoietic stem cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

21 January 2018

Hematopoietic cytokines

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Human hemato-lymphoid system mice: current use and future potential for medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Target cell specificity of two species of human interferon-alpha produced in Escherichia coli and of hybrid molecules derived from them

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Current and emerging treatment strategies for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006353

10.1126/SCITRANSLMED.3006353

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

5016610

OpenCitations bibliographic resource ID

5016610

1 reference